Sugi Predict

Sugi Predict / Compounds / SCHEMBL365865

SCHEMBL365865

SCHEMBL365865

COc1ccc(OC)c(-c2c(C(C)C)cc(C(C)C)cc2C(C)C)c1P

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.40
▸ CA2 P00918 2/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ HDAC4 P56524 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ GABRA1 P14867 1/20 0.34
▸ GABRB2 P47870 1/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ ADRA2A P08913 1/20 0.34
▸ ADRA1A P35348 1/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ FABP3 P05413 2/20 0.33
▸ FABP4 P15090 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ GFER P55789 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30381056 1.00 CA1 (0.40) CA1CA2CA7CA9HDAC4
SCHEMBL10177355 0.89 POLB (0.41) CA1CA2CA7CA9HDAC4
SCHEMBL29824511 0.81 HDAC4 (0.51) CA1CA2CA7CA9HDAC4
SCHEMBL366634 0.80 CA1 (0.40) CA1CA2CA7CA9HDAC4
SCHEMBL27951614 0.80 TAAR1 (0.40) ADRA1A
SCHEMBL26328949 0.79 POLB (0.39) CA1CA2CA7CA9HDAC4
SCHEMBL12993780 0.76 CA1 (0.37) CA1CA2CA7CA9HDAC4
SCHEMBL12929982 0.75 POLB (0.42) CA1CA2CA7CA9HDAC4
SCHEMBL12994015 0.75 CA1 (0.36) CA1CA2CA7CA9HDAC4
SCHEMBL12994013 0.75 GABRA1 (0.41) CA1CA2CA7CA9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112469690-B Method for producing arylamines 默克专利有限公司 2024-04-16 — — CN claimed
CN-112469690-A Process for producing arylamines 默克专利有限公司 2021-03-09 — — CN claimed
CN-112469690-B Method for producing arylamines 默克专利有限公司 2024-04-16 — — CN disclosed
EP-3532474-B1 4,5-ANNULATED 1,2,4-TRIAZOLONES BAYER AG (DE) 2024-03-27 — — EP disclosed
US-11932596-B2 Fluorovinyl ether compound DAIKIN INDUSTRIES, LTD. (JP) 2024-03-19 — — US disclosed
EP-3663285-B1 FORMYLPYRIDINE DERIVATIVE HAVING FGFR4 INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF ABBISKO THERAPEUTICS CO LTD (CN) 2024-01-24 — — EP disclosed
CN-114921391-B 4, 5-cyclic 1,2, 4-triazolones 拜耳股份有限公司 2024-01-02 — — CN disclosed
US-20230365524-A1 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH BAYER AKTIENGESELLSCHAFT (DE) 2023-11-16 — — US disclosed
US-11787797-B2 4,5-annulated 1,2,4-triazolones BAYER AKTIENGESELLSCHAFT (DE) 2023-10-17 — — US disclosed
US-11713304-B2 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH BAYER AKTIENGESELLSCHAFT (DE) 2023-08-01 — — US disclosed
US-20230144907-A1 METHOD FOR PRODUCING FLUOROVINYL ETHER COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2023-05-11 — — US disclosed
US-8841487-B2 Phosphine ligands for catalytic reactions ABBVIE INC. (US) 2014-09-23 — — US disclosed
CN-103857681-A Novel macrocycles as factor XIA inhibitors BRISTOL MYERS SQUIBB CO 2014-06-11 — — CN disclosed
WO-2014081718-A1 AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF T790M CONTAINING EGFR MUTANTS GENENTECH, INC. (US) 2014-05-30 — — WO disclosed
US-20130217876-A1 PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS ABBVIE INC. (US) 2013-08-22 — — US disclosed
US-20130217876-A1 PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS ABBVIE INC. (US) 2013-08-22 — — US disclosed
EP-2593226-A1 PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS Abbvie Inc. (US) 2013-05-22 — — EP disclosed
US-20120022252-A1 PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS ABBOTT LABORATORIES (US) 2012-01-26 — — US disclosed
US-20120022252-A1 PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS ABBOTT LABORATORIES (US) 2012-01-26 — — US disclosed
WO-2012009698-A1 PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS ABBOTT LABORATORIES (US) 2012-01-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713304-B2 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH DHODH, DHPS, DPYD CA1 4785/4885CA2 3827/4885CA7 4259/4885
US-20130217876-A1 PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS PHOSPHO1, PLCG2, PPIP5K2 CA1 1738/4885CA2 2370/4885CA7 1734/4885
US-20230144907-A1 METHOD FOR PRODUCING FLUOROVINYL ETHER COMPOUND RB1, AFF1, AFF2 CA1 1481/4885CA2 2070/4885CA7 1508/4885
US-11932596-B2 Fluorovinyl ether compound RB1, AFF1, AFF2 CA1 1881/4885CA2 2202/4885CA7 1956/4885
US-11787797-B2 4,5-annulated 1,2,4-triazolones CCNA1, CCNT1, CCND2 CA1 4861/4885CA2 4722/4885CA7 4275/4885
US-20230365524-A1 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH DHODH, DHPS, DPYD CA1 4785/4885CA2 3827/4885CA7 4259/4885
US-20120022252-A1 PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS PHOSPHO1, PPIP5K2, ITPA CA1 1227/4885CA2 2096/4885CA7 1251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.